정밀의료 공급망 물류 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 유형별, 서비스별, 제품별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Precision Medicine Supply Chain Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Service, By Product, By End User, By Region and Competition, 2020-2030F
세계의 정밀의료 공급망 물류 시장 규모는 2024년에 75억 1,000만 달러, 2030년에는 142억 5,000만 달러에 달할 것으로 예측되며, CAGR은 11.24%를 기록합니다.
이 시장은 종양학, 희귀질환, 유전질환에 대한 맞춤치료의 보급으로 빠르게 확대되고 있습니다. 정밀의료는 고감도 생물제제, 세포 및 유전자 치료제, 맞춤형 진단 약품의 운송을 요구하며, 정밀하고, 온도 조절이 가능하고, 시간적으로 중요한 환자별 물류 솔루션이 필요합니다. 진행 중이며, 이에 따라 민첩하고 컴플라이언스가 우수한 물류 인프라에 대한 수요가 급증하고 있습니다. 물류 프로바이더들은 안전한 역물류, 완벽한 추적성, 현장-환자 간 배송과 같은 기능에 점점 더 중점을 두고 있으며, IoT 센서, 블록체인, 실시간 분석과 같은 강화된 기술이 이 분야의 혁신을 촉진하고 있습니다. 이 분야의 혁신을 촉진하고 있습니다. 또한 비중앙집중형 임상시험 증가는 특히 복잡한 치료 요법에서 환자에게 직접 전달할 때 물류 모델을 보다 유연하고 환자 중심적으로 변화시키고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030 |
| 시장 규모 : 2024년 |
75억 1,000만 달러 |
| 시장 규모 : 2030년 |
142억 5,000만 달러 |
| CAGR : 2025-2030년 |
11.24% |
| 급성장 부문 |
핵산 치료 |
| 최대 시장 |
북미 |
시장 성장 촉진요인
세포치료 및 유전자치료 도입 증가
주요 시장 이슈
맞춤형 치료의 복잡성
주요 시장 동향
환자 직접 투여(DTP) 모델의 등장
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 정밀의료 공급망 물류 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 유형별(임상, 상업)
- 서비스별(운송, 창고, 조달·구매, 기타)
- 제품별(세포·유전자 치료(CGT), 모노클로널 항체, 핵산 치료, 백신, 기타)
- 최종사용자별(제약·바이오의약품 기업, 임상 조사기관, 기타)
- 기업별(2024)
- 지역별
- 시장 맵
제6장 북미의 정밀의료 공급망 물류 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 북미 : 국가별 분석
제7장 유럽의 정밀의료 공급망 물류 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 정밀의료 공급망 물류 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 아시아태평양 : 국가별 분석
제9장 남미의 정밀의료 공급망 물류 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 정밀의료 공급망 물류 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 중동 및 아프리카 : 국가별 분석
제11장 시장 역학
제12장 시장 동향과 발전
제13장 혼란 : 분쟁, 팬데믹, 무역장벽
제14장 Porter's Five Forces 분석
- 업계내 경쟁
- 신규 참여의 가능성
- 공급업체의 힘
- 고객의 힘
- 대체품의 위협
제15장 경쟁 구도
- Almac Group Limited
- Catalent, Inc.
- Parexel International Corporation
- IQVIA Holdings Inc.
- Thermo Fisher Scientific Inc.
- DHL International GmbH
- Federal Express Corporation
- UPS Healthcare
- GXO Logistics, Inc.
- Marken Limited
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
The Global Precision Medicine Supply Chain Logistics Market was valued at USD 7.51 Billion in 2024 and is projected to reach USD 14.25 Billion by 2030, registering a CAGR of 11.24%. This market is expanding rapidly due to the growing adoption of personalized treatments for oncology, rare diseases, and genetic conditions. Precision medicine demands the transportation of highly sensitive biologics, cell and gene therapies, and customized diagnostics-each requiring precise, temperature-controlled, time-critical, and patient-specific logistics solutions. With over 17,000 active precision medicine-related clinical trials worldwide as of 2025, the need for agile and compliant logistics infrastructure has surged. Logistics providers are increasingly focused on capabilities such as secure reverse logistics, full traceability, and site-to-patient delivery. Enhanced technologies-including IoT sensors, blockchain, and real-time analytics-are driving innovation in this space. The rise in decentralized trials is also pushing logistics models to be more flexible and patient-centric, especially for direct-to-patient delivery in complex therapy regimens.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 7.51 Billion |
| Market Size 2030 | USD 14.25 Billion |
| CAGR 2025-2030 | 11.24% |
| Fastest Growing Segment | Nucleic Acid Therapies |
| Largest Market | North America |
Key Market Drivers
Rising Adoption of Cell and Gene Therapies
The increasing use of cell and gene therapies is a key growth driver in the Precision Medicine Supply Chain Logistics Market. These personalized treatments involve a complex, highly regulated sequence-from harvesting patient samples to lab processing and returning the final product-all under strict time and temperature constraints. In 2023 and 2024 alone, the FDA approved a total of 16 cell and gene therapy products, indicating strong regulatory momentum and growing manufacturing needs. These sensitive therapies require ultra-cold or cryogenic transport to maintain integrity, driving demand for advanced cold-chain logistics, real-time GPS monitoring, and compliance-driven documentation. Providers offering complete traceability, contingency protocols, and certified infrastructure are becoming essential partners for biopharma companies.
Key Market Challenges
High Complexity of Handling Personalized Therapies
Managing personalized therapies presents significant operational challenges in the precision medicine logistics ecosystem. Unlike standard pharmaceuticals, these treatments are custom-made for individual patients and must adhere to narrow time windows and stringent environmental controls. For instance, autologous therapies involve transporting a patient's own cells to and from a specialized facility, necessitating seamless coordination, temperature integrity, and accurate labeling throughout the chain of custody. Any error-be it in customs clearance, labeling, or timing-can jeopardize treatment viability. Each shipment must align precisely with clinical and patient schedules, leaving virtually no room for deviation and amplifying the logistical complexity.
Key Market Trends
Emergence of Direct-to-Patient (DTP) Delivery Models
The growing prominence of Direct-to-Patient (DTP) delivery models is reshaping precision medicine logistics. As therapies become increasingly individualized, delivering treatment directly to patients' homes enhances accessibility and supports decentralized clinical trials. This model improves convenience, adherence, and participation, particularly for patients in remote or mobility-limited settings. DTP logistics requires precise coordination, validated cold-chain packaging, and real-time tracking systems to maintain therapy integrity during transit. Cold chain continuity and regulatory compliance are critical, especially for sensitive biologics. Logistics providers are investing in digital infrastructure and white-glove services-such as in-person delivery, patient education, and reverse logistics-to meet these complex demands. With the continued growth of telehealth and at-home diagnostics, DTP delivery is becoming integral to modern, patient-focused precision medicine.
Key Market Players
- Almac Group Limited
- Catalent, Inc.
- Parexel International Corporation
- IQVIA Holdings Inc.
- Thermo Fisher Scientific Inc.
- DHL International GmbH
- Federal Express Corporation
- UPS Healthcare
- GXO Logistics, Inc.
- Marken Limited
Report Scope:
In this report, the Global Precision Medicine Supply Chain Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Precision Medicine Supply Chain Logistics Market, By Type:
Precision Medicine Supply Chain Logistics Market, By Service:
- Transportation
- Warehousing
- Sourcing & Procurement
- Others
Precision Medicine Supply Chain Logistics Market, By Product:
- Cell & Gene Therapies (CGT)
- Monoclonal Antibodies
- Nucleic Acid Therapies
- Vaccines
- Others
Precision Medicine Supply Chain Logistics Market, By End User:
- Pharmaceutical and Biopharmaceutical Companies
- Clinical Research Organizations
- Others
Precision Medicine Supply Chain Logistics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Precision Medicine Supply Chain Logistics Market.
Available Customizations:
Global Precision Medicine Supply Chain Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Precision Medicine Supply Chain Logistics Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Clinical, Commercial)
- 5.2.2. By Service (Transportation, Warehousing, Sourcing & Procurement, Others)
- 5.2.3. By Product (Cell & Gene Therapies (CGT), Monoclonal Antibodies, Nucleic Acid Therapies, Vaccines, Others)
- 5.2.4. By End User (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Others)
- 5.2.5. By Company (2024)
- 5.2.6. By Region
- 5.3. Market Map
6. North America Precision Medicine Supply Chain Logistics Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Service
- 6.2.3. By Product
- 6.2.4. By End User
- 6.2.5. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Precision Medicine Supply Chain Logistics Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Service
- 6.3.1.2.3. By Product
- 6.3.1.2.4. By End User
- 6.3.2. Mexico Precision Medicine Supply Chain Logistics Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Service
- 6.3.2.2.3. By Product
- 6.3.2.2.4. By End User
- 6.3.3. Canada Precision Medicine Supply Chain Logistics Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Service
- 6.3.3.2.3. By Product
- 6.3.3.2.4. By End User
7. Europe Precision Medicine Supply Chain Logistics Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Service
- 7.2.3. By Product
- 7.2.4. By End User
- 7.2.5. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Precision Medicine Supply Chain Logistics Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Service
- 7.3.1.2.3. By Product
- 7.3.1.2.4. By End User
- 7.3.2. Germany Precision Medicine Supply Chain Logistics Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Service
- 7.3.2.2.3. By Product
- 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Precision Medicine Supply Chain Logistics Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Service
- 7.3.3.2.3. By Product
- 7.3.3.2.4. By End User
- 7.3.4. Italy Precision Medicine Supply Chain Logistics Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Service
- 7.3.4.2.3. By Product
- 7.3.4.2.4. By End User
- 7.3.5. Spain Precision Medicine Supply Chain Logistics Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Service
- 7.3.5.2.3. By Product
- 7.3.5.2.4. By End User
8. Asia-Pacific Precision Medicine Supply Chain Logistics Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Service
- 8.2.3. By Product
- 8.2.4. By End User
- 8.2.5. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Precision Medicine Supply Chain Logistics Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Service
- 8.3.1.2.3. By Product
- 8.3.1.2.4. By End User
- 8.3.2. India Precision Medicine Supply Chain Logistics Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Service
- 8.3.2.2.3. By Product
- 8.3.2.2.4. By End User
- 8.3.3. South Korea Precision Medicine Supply Chain Logistics Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Service
- 8.3.3.2.3. By Product
- 8.3.3.2.4. By End User
- 8.3.4. Japan Precision Medicine Supply Chain Logistics Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Service
- 8.3.4.2.3. By Product
- 8.3.4.2.4. By End User
- 8.3.5. Australia Precision Medicine Supply Chain Logistics Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Service
- 8.3.5.2.3. By Product
- 8.3.5.2.4. By End User
9. South America Precision Medicine Supply Chain Logistics Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Service
- 9.2.3. By Product
- 9.2.4. By End User
- 9.2.5. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Precision Medicine Supply Chain Logistics Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Service
- 9.3.1.2.3. By Product
- 9.3.1.2.4. By End User
- 9.3.2. Argentina Precision Medicine Supply Chain Logistics Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Service
- 9.3.2.2.3. By Product
- 9.3.2.2.4. By End User
- 9.3.3. Colombia Precision Medicine Supply Chain Logistics Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Service
- 9.3.3.2.3. By Product
- 9.3.3.2.4. By End User
10. Middle East and Africa Precision Medicine Supply Chain Logistics Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Service
- 10.2.3. By Product
- 10.2.4. By End User
- 10.2.5. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Precision Medicine Supply Chain Logistics Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Service
- 10.3.1.2.3. By Product
- 10.3.1.2.4. By End User
- 10.3.2. Saudi Arabia Precision Medicine Supply Chain Logistics Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Service
- 10.3.2.2.3. By Product
- 10.3.2.2.4. By End User
- 10.3.3. UAE Precision Medicine Supply Chain Logistics Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Service
- 10.3.3.2.3. By Product
- 10.3.3.2.4. By End User
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Disruptions: Conflicts, Pandemics and Trade Barriers
14. Porters Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Almac Group Limited
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
- 15.2. Catalent, Inc.
- 15.3. Parexel International Corporation
- 15.4. IQVIA Holdings Inc.
- 15.5. Thermo Fisher Scientific Inc.
- 15.6. DHL International GmbH
- 15.7. Federal Express Corporation
- 15.8. UPS Healthcare
- 15.9. GXO Logistics, Inc.
- 15.10. Marken Limited
16. Strategic Recommendations
17. About Us & Disclaimer
